Previous Page  7 / 36 Next Page
Information
Show Menu
Previous Page 7 / 36 Next Page
Page Background

Volume 2, Issue 3(Suppl)

Oncol Cancer Case Rep

ISSN: 2471-8556 an open access journal

Page 29

Notes:

Cancer Therapy & Biomarkers 2016

December 05-07, 2016

conferenceseries

.com

CANCER THERAPY,

BIOMARKERS & CLINICAL RESEARCH

15

th

World Congress on

December 05-07, 2016 Philadelphia, USA

Pfetin as a risk factor of recurrence in Gastrointestinal Stromal Tumors

Shunsuke Sakuraba

Juntendo Shizuoka Hospital, Japan

W

e have proposed Pfetin as a new, strong prognostic biomarker in resected Gastrointestinal Stromal Tumors (GISTs).

Pfetin is a potassium channel protein. It is highly expressed in fetal cochlea and in the brain, consistent with the fact

that the origin of GIST is Cajal cells, and neuronal cells in the gut. Pfetin was discovered by using a proteomics approach and

its usefulness as a prognostic biomarker has been reported. We examine Pfetin expression immunohistochemically using par-

affin-embedded tissues, and when more than 20% of tumor cells are stained with the anti-Pfetin antibody, they are considered

to be Pfetin-positive. Pfetin expression and tumor metastasis were inversely related and GIST with Pfetin-negative status has

a poorer prognosis than Pfetin-positive GIST. We also have reported the fact that Pfetin is an independent predictor of recur-

rence/metastasis for completely resected primary, localized GIST. In our study, 13 cases were Pfetin-negative and 5/13 of these

cases recurred. Conversely, 32 cases were Pfetin-positive and 2/32 of these cases recurred. (p=0.002) Pfetin is a strong prognos-

tic biomarker and useful in selecting adjuvant therapy. We reviewed literatures and summarized Pfetin in GIST.

Biography

Shunsuke Sakuraba has completed his MD from Juntendo University. He works in the Department of Surgery at Juntendo Shizuoka Hospital and specializes in

Open Surgery, Laparoscopic Surgery and Endoscopic Surgery. He has published 2 papers about GIST and MALT lymphoma of GI tract.

lunlun8shunsuke@gmail.com

Shunsuke Sakuraba, Oncol Cancer Case Rep 2016,2:3(Suppl)

http://dx.doi.org/10.4172/2471-8556.C1.002